Drug Shortage Report for RANITIDINE
Report ID | 47846 |
Drug Identification Number | 02385953 |
Brand name | RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-04-24 |
Estimated end date | |
Actual end date | 2018-07-02 |
Shortage status | Resolved |
Updated date | 2018-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-31 | French | Compare |
v3 | 2018-07-31 | English | Compare |
v2 | 2018-05-01 | French | Compare |
v1 | 2018-05-01 | English | Compare |
Showing 1 to 4 of 4